Skip to main content
Premium Trial:

Request an Annual Quote

BGI Bid to Acquire Complete Genomics Passes US Antitrust Hurdle; Tender Offer Extended Again

NEW YORK (GenomeWeb News) – BGI-Shenzhen and Complete Genomics said today that their proposed merger has cleared US antitrust review.

The companies said that they have received early termination of the Hart-Scott-Rodino waiting period from the Federal Trade Commission regarding BGI's $118 million bid for Complete.

The news comes one week after the Committee on Foreign Investment in the United States cleared the proposed acquisition.

BGI also said today that it has extended its tender offer for Complete's shares to midnight EST on Jan 11. The offer had originally been scheduled to expire on Dec. 31, 2012, and was later extended to expire at midnight today.

The Scan

University of Michigan President Fired

Mark Schlissel, the president of the University of Michigan, has been fired after an investigation into allegations he had an affair with a subordinate, the Washington Post reports.

Recommendation to Drop Charges

The Wall Street Journal says federal prosecutors recommended charges against MIT's Gang Chen, who was caught up by the China Initiative, be dropped.

Mix 'Em Together

The Guardian reports Moderna is planning to have a combination SARS-CoV-2, influenza, and RSV vaccine by the 2023 flu season.

PNAS Papers on Earth BioGenome Project, SETX Knockouts, Pig Model of Cystic Fibrosis

In PNAS this week: Earth BioGenome Project reports progress, analysis of cells missing the progressive neurodegenerative disease-linked SETX gene, and more.